To correct errors in Table 1 of the original publication regarding clinical characteristics of follicular dendritic cell sarcoma (FDCS) associated with IgG4-related disease.
Approach:
Correction Details: A post-publication self-check identified sequential reference number errors in Table 1, which were corrected.
Key Findings:
Reference numbers in Table 1 were incorrectly sequenced and have been updated.
Corrections include revisions to multiple citations from Li Y etal. (2023) to Liu X etal. (2021).
Interpretation:
The authors acknowledge responsibility for the oversight during the proofreading stage.
Limitations:
Errors were present in the published table, which may affect the interpretation of the clinical characteristics presented.
Conclusion:
The original version of the article has been updated with the corrected Table 1.
Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.
